• Home
  • Donate
  • Contact Us

 

Past Meetings

2022 ITSCC Annual Meeting

Thursday, March 24

2022 Oscar Colegio Memorial Lecture

Surgical Management of Skin Cancers in Immunosuppressed Patients

Kevin Emerick, MD
Co-Director, Non Melanoma Skin Cancer Multidisciplinary Care and Program
Associate Professor of Otolaryngology-Head and Neck Surgery
Massachusetts Eye and Ear Hospital

Clinical Conundrums

Business Meeting

Virtual E-Posters


2021 ITSCC Annual Meeting (Virtual)

Saturday, March 20, 2021

Oscar Colegio Memorial Lecture

Rare Skin Cancers in Organ Transplant Recipients: An Update

Dr. Catherine Harwood, MA, PhD, FRCP
Professor of Dermatology, Royal London Hospital and Blizzard Institute, Queen Mary University of London

Scientific Abstracts:

  • “No difference in skin cancer rates by transplanted organ type after the initial skin cancer.” Dr. Lee Wheless, Vanderbilt University
  • “Immunosuppressive regimens with tacrolimus and mTOR inhibitors are associated with an increased risk of cutaneous squamous-cell carcinoma metastases in organ transplant recipients: the SCOPE/ITSCC metastases study.” Dr. Jan Nico Bouwes Bavinck, Leiden University Medical Center
  • “Expression of CD155, PD-1 and PD-L1 in Non-Melanoma Skin Cancer: Implications for Treatment of Advanced Disease.” Dr. Melodi Whitley, Duke University
  • “CD73 is an immunometabolic biomarker of poor prognosis in patients with primary cutaneous squamous cell carcinoma and hematologic malignancy.” Dr. Stephanie Jackson Cullison, New York University
  • “Identification of clinical, intrinsic, extrinsic skin aging factors and MC1R variants predisposing to non-melanoma skin cancer (NMSC) in immunosuppressed organ transplant recipients – a case-control study.” Dr. Liliane Borik-Heil, Medical University of Vienna
  • “Clinical Outcomes of Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma in Immunosuppressed Patients.” Dr. Jake Wang, Yale University

Tumor Board:
Case Presentations: Dr. Patrick Mulvaney, Brigham and Womens' Hospital; Dr. Amarachi Eseonu, Johns Hopkins

Panelists: Dr. Kristin Bibee, Assistant Professor of Dermatology, Johns Hopkins; Dr. Eric Nolley, Assistant Professor of Medicine, Pulmonary and Critical Care, Johns Hopkins; Dr. David Carr, Associate Professor, Mohs Surgery and Dermatologic Oncology, Ohio State University; Dr. John Carucci, Professor of Dermatology, NYU Langone Medical Center

Recording: 2021 ITSCC Virtual Annual Meeting
https://zoom.us/rec/share/cbKomOkKiG_uQA4-_CXpS0r22VUEHgWWZThRrtwR1_9g9Mymyo7MeQLuat3jXZkk.nW-zTf22i6Oyak3K

Access Code: ITSCC#2021

ITSCC

2020 ITSCC Transplant Symposium at the Annual Meeting of the Society for Investigative Dermatology

Agenda


2020 ITSCC Annual member Meeting (Virtual)

Thursday, March 19, 2020
Recording: 2020 ITSCC Virtual Annual Member Meeting Video
Handout: Presentation from Dr. Lushniak


2019 ITSCC Annual Member Meeting

Thursday, February 28, 2019
Washington, DC, USA


2018 ITSCC Retreat

Thursday, September 27 – Sunday, September 30, 2018
Essex Conference & Retreat Center
Essex, Massachusetts, USA


ITSCC at the International Investigative Dermatology (IID) 2018 Meeting

Thursday, May 17, 2018
Orlando, Florida, USA
Visit the IID website


2018 ITSCC Member Meeting at the AAD

Thursday, February 15, 2018
San Diego, California, USA


ITSCC Transplant Dermatology Symposium at SID 2017

ITSCC colleagues joined together for the second annual ITSCC Transplant Dermatology Symposium on Thursday, April 27 at the annual meeting of the Society for Investigative Dermatology in Portland, Oregon.  The symposium was directed by Oscar Colegio, MD, PhD. Four oral abstracts were presented at this Symposium: 

  • Genomic analysis reveals drivers of high-risk subsets of cutaneous squamous cell carcinoma
  • Tran Nguyen, H. Lee Moffitt Cancer Center & Research Institute, Kimal Rajapakshe, Baylor College of Medicine, Vida Chitsazzadeh, University of Texas Health Sciences Center Houston, Kimberly Truong, H. Lee Moffitt Cancer Center & Research Institute, Chrysalyne Schmults, Harvard Medical School, AP South, TJU, Raymond Cho, University of California, San Francisco, Cristian Coarfa, Baylor College of Medicine, K Tsai, RDEB SCC Sequencing Consortium.
  • Risk factors of high frequency basal cell carcinoma: Gender, histologic subtypes, anatomic distribution, and associated immunosuppression
  • Karen Kuo, Stanford University School of Medicine, Hyunje    Cho, Stanford University School of Medicine, Prag Batra, Stanford University School of Medicine, Shufeng Li, Stanford University School of Medicine, Kerri Rieger, Stanford Dermatology, Jean Tang,  Stanford University, Kavita Sarin, Stanford University.
  • Cutaneous infection rates are not affected by chronic HIV(+) or HCV(+) coinfection in organ transplant recipients
  • Kumar Nadhan, Drexel Dermatology,  Scott Shipman, Drexel Dermatology, Erin Buchanan, Drexel Dermatology, Gregory Malat, Drexel Surgery, Alden Doyle, University of Virginia, Christina Chung, Drexel Dermatology
  • IL-22 promotes early aggressive behavior of cutaneous squamous cell carcinoma (SCC); A murine xenograft model
  • Melody Abikhair,  Dept of Derm, NYU Langone Med Ctr, Nazanin Roudiani, Dept of Derm, NYU Langone Med Ctr, Alexis Santana, Dept of Derm, NYU Langone Med Ctr, Jie Chen, Inst for Ped Urol, Weill Cornell Medicine, Diane Felsen, Inst for Ped Urol, Weill Cornell Medicine, John Carucci, Dept of Derm, NYU Langone Med Ctr.       

Congrats to all on a successful event.

ITSCC
(L-R) Christina Chung, Oscar Colegio, Melody Abikhair, Tran Nguyen, Karen Kuo.

ITSCC Members Present “Topics in Transplant” at 2017 ACMS Annual Meeting

ITSCC Past President Fiona Zwald, MD, MRCPI moderated a session, “Topics in Transplant from ITSCC” at the 2017 Annual Meeting of the American College of Mohs Surgery at the Hilton San Francisco Union Square on Saturday, April 29.

Zwald and speakers Matthew Fox, MD and Justin Leitenberger, MD discussed the importance of obtaining a medical and drug history in the evaluation of an immunosuppressed patient who presents with an aggressive skin cancer; description of pre-op and post-op management of aggressive skin cancer in immunosuppressed patients; and use of adjuvant therapies in the immunosuppressed patient with skin cancer.

ITSCC
(L-R) Justin Leitenberger, MD; Fiona Zwald, MD; Matthew Fox, MD
ITSCC